Pap/phen/prostag/atropine INJ 150mg/7.5mg/75mcg/1mg recall: Sterility Concern
PAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS…
Why was Pap/phen/prostag/atropine INJ 150mg/7.5mg/75mcg/1mg recalled?
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: 66369, BUD: 11/06/2022; 66540, BUD: 11/09/2022
- Product
- PAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS…
- Recalling firm
- Pharmacy Plus, Inc. dba Vital Care Compounder
- Quantity
- 2 vials
- Distribution
- AL, LA, MS, and TN
- Recall date
- November 9, 2022
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)